Invitrocue Chief Scientific Officer, Dr. Zahra Dantes, will be presenting our latest findings on our current validation study regarding breast cancer at ESMO Breast Cancer 2022, 3-5 May, in Berlin.
Visit esmo.org to register your interest.
1
Join us as Dr. Michael Wehr shares his expertise on High Content Pathway Profiling in Neurological Disease Models.
Find more information & Register here: invitrocue.com/30NovWebinarT…
Invitrocue retweeted
Join us as Dr. Chen Qing Feng shares his expertise in developing mouse models with various Human Biological Systems and the application.
Find more information & Register here: invitrocue.com/28OctWebinarT…
Join us as Dr. Chen Qing Feng shares his expertise in developing mouse models with various Human Biological Systems and the application.
Find more information & Register here: invitrocue.com/28OctWebinarT…
Invitrocue retweeted
We're looking forward to the first Spain Symposium ! #oncology #PDO
New York, Canada Time: 10AM
Singapore, Hong Kong: 11PM
Register here: invitrocue.com/18Feb21Webina…
Invitrocue retweeted
We are 1 day away ! Join us to hear from Dr. Samuel Brennan from GenieUS about Development of Personalised Medicines for Sporadic ALS. Register here: invitrocue.com/3FebWebinarTW
#ALS #Sporadic #PersonalisedMedicines
We are 1 day away ! Join us to hear from Dr. Samuel Brennan from GenieUS about Development of Personalised Medicines for Sporadic ALS. Register here: invitrocue.com/3FebWebinarTW
#ALS #Sporadic #PersonalisedMedicines
We're looking forward to the first Spain Symposium ! #oncology #PDO
New York, Canada Time: 10AM
Singapore, Hong Kong: 11PM
Register here: invitrocue.com/18Feb21Webina…
Invitrocue retweeted
Join us as Dr. Samuel Brennan from GenieUS , shares about Amyotrophic lateral sclerosis (ALS) disease using multi-omic analysis. #ALS #Sporadic
Find more information & Register here: invitrocue.com/3FebWebinarTW
Join us as Dr. Samuel Brennan from GenieUS , shares about Amyotrophic lateral sclerosis (ALS) disease using multi-omic analysis. #ALS #Sporadic
Find more information & Register here: invitrocue.com/3FebWebinarTW
We hope the Webinar [New Trends in Drug Discovery: Robotics and AI ] has been insightful. Please keep a look out as we update on the next Webinar or Conference !
RT @Invitrocue: Join us at 3pm (Singapore Time) today as we learn about how automation and machine learning applications in drug discovery process ! #AI #Robotics #Drugdiscovery
Register here: invitrocue.com/4nov/
Invitrocue retweeted
Bringing together recent advances in life sciences automation and machine learning applications for drug discovery, new partnerships evolve that allow for game-changing improvements in the drug discovery process.#AI #Robotics #Drugdiscovery
Register here: invitrocue.com/4nov/
Bringing together recent advances in life sciences automation and machine learning applications for drug discovery, new partnerships evolve that allow for game-changing improvements in the drug discovery process.#AI #Robotics #Drugdiscovery
Register here: invitrocue.com/4nov/
Invitrocue to establish Joint Venture in Brazil with commitment to offer thousands of patient tests | Learn more: ow.ly/9jdi50ynTHg
"The war against cancer will be fought better with improved decision making tools" Read how Invitrocue is helping doctors make better decisions regarding treatment options | Nick Sundich reports for Stockhead: stockhead.com.au/health/the-…
1
4
Invitrocue establishes Hong Kong laboratory | Learn more: asx.com.au/asxpdf/20190927/p… $IVQ
Invitrocue clinical validation studies underway in Germany | Learn more: ow.ly/GS2J50wpS6g $IVQ
Invitrocue Limited (ASX:IVQ) is an innovative life sciences company that specialises in developing ground-breaking 3D cell-based models from tumor tissues | Learn more: invitrocue.com $IVQ
1
4
"There’s no question of demand for Onco-PDO at a macro level, with 15 million new cancer
cases a year and this number is expected to double by 2040" | Read Biotech Daily's Market Report featuring Invitrocue here: biotechdaily.com.au
1















